The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Wed., Aug. 24, 7:54 AM

Slide #22. Amarin Corporation plc Secondary Offering

Company: Amarin Corporation plc (NASDAQ:AMRN)
Date announced: 8/10/2016
Shares Offered: 21,100,000
Date of Pricing: 8/11/2016
Price Per Share: $2.85
Secondary Offering Details: Amarin Corporation plc (NASDAQ:AMRN) today announced that it has commenced an underwritten public offering of its American Depositary pursuant to a shelf registration. All of the shares in the proposed offering are to be sold by Amarin. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. -updated 8/11- Amarin Corporation plc (NASDAQ:AMRN) today announced the pricing of an underwritten public offering of 21,100,000 American Depositary Shares ("ADSs") at a price to the public of $2.85 per ADS. The net proceeds to the company from this offering are expected to be approximately $56.1 million, after deducting underwriting discounts and commissions and other estimated offering expenses. The offering is expected to close on or about August 16, 2016, subject to customary closing conditions.

Amarin is a biopharmaceutical company. Co. is focused on the commercialization and development of therapeutics for cardiovascular health. Co.'s main product, Vascepa® (icosapent ethyl) capsules, is for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Co. refers this indication for Vascepa as the MARINE indication. Vascepa is available in the U.S. by prescription only. Co. is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol, levels which Co. refer to as mixed dyslipidemia.
Open the AMRN Page at The Online Investor »

Company Name:  Amarin Corp Plc
Sector:  Biotechnology
Number of ETFs Holding AMRN:  6
Total Market Value Held by ETFs:  $8.22M

Open the AMRN Page at The Online Investor (in a new window) »

August 24, 2016    7:54 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.